PGI2-RECEPTORS AND MOLECULAR MECHANISMS IN PLATELETS AND VASCULATURE - STATE OF THE ART

被引：43

作者：

OLIVA, D

NICOSIA, S

机构：

来源：

PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1987年 / 19卷 / 11期

关键词：

D O I：

10.1016/0031-6989(87)90010-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：735 / 765

页数：31

共 74 条

[31]

KUKOVETZ WR, 1979, J CYCLIC NUCL PROT, V5, P469

[32]

Lapetina E G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P115

[33] THE USE OF STABLE PROSTAGLANDINS TO INVESTIGATE PROSTACYCLIN (PGI2)-BINDING SITES AND PGI2-SENSITIVE ADENYLATE-CYCLASE IN HUMAN-PLATELET MEMBRANES [J].

LOMBROSO, M ;

NICOSIA, S ;

PAOLETTI, R ;

WHITTLE, BJR ;

MONCADA, S ;

VANE, JR .

PROSTAGLANDINS, 1984, 27 (02) :321-333

[34]

MCDONALD JW, 1974, J LAB CLIN MED, V84, P111

[35] 6-KETO-PROSTAGLANDIN-E1 IS NOT EQUIPOTENT TO PROSTACYCLIN (PGI2) AS AN ANTI-AGGREGATORY AGENT [J].

MILLER, OV ;

AIKEN, JW ;

SHEBUSKI, RJ ;

GORMAN, RR .

PROSTAGLANDINS, 1980, 20 (02) :391-400

[36] CIGARETTE-SMOKING DOES NOT AFFECT PGI2 PLATELET RECEPTORS [J].

MODESTI, PA ;

FORTINI, A ;

ABBATE, R ;

GENSINI, GF .

THROMBOSIS RESEARCH, 1985, 37 (02) :343-346

[37] 8TH GADDUM MEMORIAL LECTURE UNIVERSITY-OF-LONDON-INSTITUTE-OF-EDUCATION DECEMBER 1980 - BIOLOGICAL IMPORTANCE OF PROSTACYCLIN [J].

MONCADA, S .

BRITISH JOURNAL OF PHARMACOLOGY, 1982, 76 (01) :3-31

[38] PROSTACYCLIN - ITS BIOSYNTHESIS, ACTIONS AND CLINICAL POTENTIAL [J].

MONCADA, S ;

VANE, JR .

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1981, 294 (1072) :305-329

[39] ANTI-PLATELET AGGREGATING AND DISAGGREGATING ACTIVITIES OF 6,9-METHANO PGI2 [J].

MORITA, A ;

MORI, M ;

HASEGAWA, K ;

KOJIMA, K ;

KOBAYASHI, S .

LIFE SCIENCES, 1980, 27 (08) :695-701

[40] A COMPARATIVE-STUDY OF PGI2 AND 2 ANALOGS (FCE-21292 AND FCE-21258) INVITRO AND INVIVO [J].

MORLEY, J ;

PAGE, CP ;

PAUL, W ;

MONGELLI, N ;

CESERANI, R ;

GANDOLFI, C .

PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1983, 11 (04) :391-399

← 1 2 3 4 5 6 7 8 →